GLOBAL & USA TRANSDERMAL DRUG DELIVERY MARKET TO 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

Tuesday 16 December 2014, Amsterdam

“GLOBAL & USA TRANSDERMAL DRUG DELIVERY MARKET TO 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation” is a dedicated report on the transdermal drug delivery industry and its impact on the USA and global markets.

‘This cutting edge report on the GLOBAL & USA TRANSDERMAL DRUG DELIVERY MARKET TO 2020 maximises our clients ability to analyse this growing industry and identify key business opportunities and strategies. We constantly strive to provide our clients with the most up-to-date and relevant information that they require for this highly competitive industry’ stated Deirdre Kelly, PhD.


To this end, GLOBAL & USA TRANSDERMAL DRUG DELIVERY MARKET TO 2020 is presented as follows:

• By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)
• By Geography (Global, USA)
• By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems)
• By Sub-market (Generics, Women’s Health, Analgesics, Neuropathic Pain)

A wealth of financial data & business strategy information is provided including:

• Up-to-date company financials, sales & revenue figures
• Revenue and market forecasts
• Business model strategies for drug delivery, pharmaceutical and biotechnology companies
• Comprehensive account of company products, financials & portfolios

SWOT, Economic & Regulatory Environment specifics include:

• Key strengths, weaknesses and threats influencing leading player position within the market
• Technologies driving the market (e.g., chemical enhancers, microneedles)
• Top fastest growing market segments and emerging opportunities
• Top pharmaceutical companies within the market
• Comprehensive product portfolios, R&D activity and pipeline products
• M&A activity and future strategies of top companies
• High demand and unmet need enhances the market   
• Challenges of the transdermal drug delivery market

This report highlights a number of significant companies and gives details of their operations, products, financials and business strategy.

• Actavis
• Actelion
• GlaxoSmithKline
• Bayer
• Mylan Pharmaceuticals
• Novartis
• Upsher-Smith
• Ascend Therapeutics
• AMAG Pharmaceuticals (Lumara Health, KV Pharm/Ther-Rx Corp)
• Janssen Pharmaceuticals
• Noven Pharmaceuticals
• ProStrakan
• Shire
• Hercon Pharmaceutical
• Kremers Urban Pharmaceuticals
• Nitto Denko
• Teva Pharmaceutical Industries
• Endo International
• Teikoku USA
• Boehringer Ingelheim
• 3M
• UCB
• ParPharm

What clients will gain:

• An in-depth understanding of the global and USA transdermal drug delivery market and it’s environment
• Current market facts, figures and product lines of key players in the industry
• Emerging trends in key markets such as the USA
• Knowledge of how the transdermal drug delivery market will integrate into the global healthcare market
• Strategies on how to adapt and restructure current business models to this industry

Who should read this report?

• Pharmaceutical, biotechnology and diagnostic companies with an interest in drug delivery systems
• Industry professionals and business strategists will discover key information to propel their policies
• Investors will gain inside information to dominant players in the industry and future forecasts
• Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment

This report will tell you if the companies mentioned are:

• Strong, competitive players
• Pooling their resources for specific growth and therapeutic areas
• Investing strategically in R&D
• Have a history of strategic M&A activity

This detailed report is supported with 320 figures and tables over 280 pages and profiles the main pharmacos in the transdermal drug delivery market.